Metraipolis › archive › dc_7b6061544c8f

Real-world data-based assessment of therapy-related myeloid neoplasms after poly(ADP-ribose) polymerase inhibitor treatment in ovarian cancer — Europe PMC PMID:41695357

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41695357
DOI
10.3389/fonc.2026.1728766
License (as archived)
solo-consultazione
Archived
2026-11-06T11:05:42.706Z
SHA-256 of the archived text
d10626f48640de5e66a9c4813be095c62828c3c6f7cdc97c4bf0ac257122a43c
Stable URL of this page
https://metraipolis.com/documento/dc_7b6061544c8f

How to cite

Real-world data-based assessment of therapy-related myeloid neoplasms after poly(ADP-ribose) polymerase inhibitor treatment in ovarian cancer — Europe PMC PMID:41695357 — Europe PMC (en), https://europepmc.org/article/MED/41695357 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_7b6061544c8f (Metraipolis archive dc_7b6061544c8f, sha256 d10626f48640de5e66a9c4813be095c62828c3c6f7cdc97c4bf0ac257122a43c)
BibTeX
@misc{dc7b6061544c8f,
  title = {Real-world data-based assessment of therapy-related myeloid neoplasms after poly(ADP-ribose) polymerase inhibitor treatment in ovarian cancer — Europe PMC PMID:41695357},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41695357},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_7b6061544c8f; sha256 d10626f48640de5e66a9c4813be095c62828c3c6f7cdc97c4bf0ac257122a43c},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41695357. Agents can read the archived copy with the MCP tool read_document.